GeneBioTech Co Stock

GeneBioTech Co Receivables

Accounts Receivable of GeneBioTech Co (086060.KQ) as of Sep 7, 2026.

Receivables

0.00KRW

Last updated:

Accounts Receivable of GeneBioTech Co is 2026 0.00 KRW. Accounts Receivable of GeneBioTech Co was 2025 13.55 B KRW. It decreases by % lower compared to the previous year.

The GeneBioTech Co Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2018
8.81 B KRW
Jan 1, 2019
7.75 B KRW
Jan 1, 2020
6.72 B KRW
Jan 1, 2021
10.25 B KRW
Jan 1, 2022
14.15 B KRW
Jan 1, 2023
11.74 B KRW
Jan 1, 2024
13.55 B KRW
Jan 1, 2025
0.00 KRW
The GeneBioTech Co Receivables history
YEARReceivablesYoY
0.00KRW-100.00%
13.55 BKRW+15.45%
11.74 BKRW-17.05%
14.15 BKRW+38.08%
10.25 BKRW+52.60%
6.72 BKRW-13.35%
7.75 BKRW-11.99%
8.81 BKRW+1.63%
8.67 BKRW+1.25%
8.56 BKRW-5.09%
9.02 BKRW+5.75%
8.53 BKRW-6.90%
9.16 BKRW+18.51%
7.73 BKRW-4.45%
8.09 BKRW+144.82%
3.30 BKRW+24.49%
2.65 BKRW-19.53%
3.30 BKRW+18.34%
2.79 BKRW+18.04%
2.36 BKRW+48.77%
1.59 BKRW+18.79%
1.34 BKRW-43.25%
2.35 BKRW—
Access this data via the Eulerpool API
Get Free API Key

GeneBioTech Co Stock analysis

What does GeneBioTech Co do? GeneBioTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneBioTech Co stock

On Eulerpool you can find the complete historical development of Accounts Receivable GeneBioTech Co since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's GeneBioTech Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — GeneBioTech Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — GeneBioTech Co